Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 4.83 GBp
Change Today -0.125 / -2.53%
Volume 1.5M
As of 11:30 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sven Jan-Anders Karlsson Ph.D.

Chief Executive Officer and Executive Director,Verona Pharma plc
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
60390,457 GBP
As of Fiscal Year 2014


Dr. Sven Jan-Anders Karlsson, PhD, has been the Chief Executive Officer at Verona Pharma plc since June 1, 2012. Dr. Karlsson has broad pharmaceutical and biotechnology R&D and corporate experience. He served as the Chief Executive Officer at S*BIO, a Singapore and US based biotechnology company focused on the discovery and development of novel small molecule anti-cancer drugs. Before S*BIO, Dr. Karlsson served as Executive Vice President of Pharma Global Research at ...

Read Full Background

Corporate Headquarters*

3 More London Riverside
London, Greater London SE1 2RE

United Kingdom

Phone: 44 20 3283 4200
Fax: --

Board Members Memberships*

Chief Executive Officer and Executive Director


There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary180,000 GBP
Bonus81,667 GBP
Total Annual Compensation261,667 GBP

Stock Options*

All Other Compensation64,901 GBP
Exercisable Options5,000,002
Unexercisable Options7,999,998
Total Number of Options13,000,000

Total Compensation*

Total Annual Cash Compensation326,568 GBP
Total Short Term Compensation261,667 GBP
Other Long Term Compensation64,901 GBP
Total Calculated Compensation390,457 GBP
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRP:LN 4.83 GBp -0.125


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERONA PHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at